Rare diseases
Investigational molecules
Locations
Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer
BelgiumStudy on the Safety and Effectiveness of MK-1308A, Pembrolizumab, and Lenvatinib for Patients with Advanced Liver Cancer
ItalyStudy on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer
DenmarkStudy of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
FranceStudy on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer
BelgiumStudy of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer
DenmarkStudy on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Inflammatory Bowel Strictures in Crohn's Disease Patients
SpainStudy on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease
ItalyStudy on the Use of Ibuprofen and Paracetamol for Treating Patent Ductus Arteriosus in Extremely Premature Infants
IrelandStudy on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder
BulgariaStudy of DKN-01 and Tislelizumab with Chemotherapy for Adults with Advanced Gastric or Gastroesophageal Cancer
GermanyStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
